PROF. ALEX, CASMIR UWADIEGWU AKPA, SFIARSA

PROF. ALEX, CASMIR UWADIEGWU AKPA, SFIARSA

Council Member

The Acting Director-General / CEO National Biotechnology Development Agency (NABDA), Abuja

Prof. Alex, Casmir Uwadiegwu Akpa has been appointed as the Acting Director-General / CEO of the National Biotechnology Development Agency (NABDA). An indigene of Mgbowo in Awgu Local Government Area of Enugu State, Nigeria, Prof Akpa is the most Senior Director of NABDA and has served as Director and Head of the Medical Biotechnology Department in NABDA from 1st June, 2008 to 1st June, 2016. Before his recent appointment, he was a Research Director in the same Department. According to the appointment letter dated 31st May, 2018 and signed by the Honourable Minister of Science and Technology, Dr. Ogbonnaya Onu.

Professor Akpa qualifications include Doctor of Philosophy (PhD) degree in Medical Parasitology and Epidemiology (including Medical Entomology) with special reference to Onchocerciasis (River Blindness) obtained the renowned Ahmadu Bello University, Zaria, Nigeria in May 1988; Master of Science (MSc) in Medical Parasitology and Entomology (Tropical Diseases Epidemiology) was supported by the WHO based on performance from the University of Jos in 1980 and Bachelor of Science (B.Sc) (Hons) degree in Zoology with emphasis on Parasitology and Entomology was carried out on Federal Government of Nigeria (FGN) Scholarship from the prestigious University of Ibadan in June 1977

A professor of Pharmaceutical Microbiology and Biotechnology; Prof. Akpa is a Fellow of the World Health Organisation (FWHO); a Fellow of the Royal Society of Tropical Medicine and Hygiene(FRSTMH) and a Fellow of the Institute of Corporate Administration of Nigeria (FCAI). Prof Alex Akpa presently has four patents granted for his original inventions. Prof Akpa has won several international grants for the development of medical biotechnology in Nigeria.

Professor Akpa is married and blessed with children.

 

 

Address

N/A

Phone

N/A

Email

N/A

Website

N/A

SUBSCRIBE TO OUR NEWSLETTER

SUBSCRIBE NOW